» Articles » PMID: 15766575

Efficient Replication of a Full-length Hepatitis C Virus Genome, Strain O, in Cell Culture, and Development of a Luciferase Reporter System

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2005 Mar 16
PMID 15766575
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Recently we reported a subgenomic hepatitis C virus (HCV) replicon derived from HCV (HCV-O strain) infected in non-neoplastic human hepatocyte PH5CH8. In this study, we developed a genome-length dicistronic HCV RNA from HCV-O. A cured HuH-7 cell line (sOc) was obtained from a cloned subgenomic replicon cell line (sO) by interferon (IFN) treatment and used for transfection with genome-length HCV RNA. One cloned cell line, O, was successfully selected by G418 treatment following the introduction of genome-length HCV RNA into sOc cells, and the robust expression of HCV RNA and proteins was confirmed. Oc, a cured cell line, was also obtained from the cloned cell line (O) by IFN treatment. The number of colonies increased drastically when genome-length HCV RNA was introduced into Oc cells. However, the cloned cured cell lines, sOc and Oc, differed in their colony formation efficiency despite their common origin. This result suggests that even a cloned cell line can change its characteristics during cell culture. Sequence analysis of HCV RNA from the O cells revealed an amino acid substitution in the NS3 helicase region (K1609E). This substitution worked as an adaptive mutation in transient reporter and colony formation assays. Using the advantages of this adaptive mutation and of Oc cells in colony formation, we established the first cell line in which genome-length dicistronic HCV RNA encoding a luciferase gene replicated efficiently. This culture system is useful tool for the study of HCV replication and mass screening for anti-HCV reagents.

Citing Articles

Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors.

Toyodome A, Mawatari S, Eguchi H, Takeda M, Kumagai K, Taniyama O Sci Rep. 2024; 14(1):16363.

PMID: 39013947 PMC: 11252252. DOI: 10.1038/s41598-024-67169-5.


Sofosbuvir induces gene expression for promoting cell proliferation and migration of hepatocellular carcinoma cells.

Tsai W, Cheng J, Liu P, Chang T, Sun W, Chen W Aging (Albany NY). 2022; 14(14):5710-5726.

PMID: 35833210 PMC: 9365546. DOI: 10.18632/aging.204170.


Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities.

Gu W, Ueda Y, Dansako H, Satoh S, Kato N FASEB Bioadv. 2021; 3(5):356-373.

PMID: 33977235 PMC: 8103717. DOI: 10.1096/fba.2020-00107.


Cytoplasmic dsRNA induces the expression of and mRNAs in differentiated human cells.

Wang G, Kouwaki T, Mugikura K, Okamoto M, Takaki H, Funami K J Biol Chem. 2019; 294(50):18969-18979.

PMID: 31615841 PMC: 6916484. DOI: 10.1074/jbc.RA119.009783.


Nir2 Is an Effector of VAPs Necessary for Efficient Hepatitis C Virus Replication and Phosphatidylinositol 4-Phosphate Enrichment at the Viral Replication Organelle.

Wang H, Tai A J Virol. 2019; 93(22).

PMID: 31484747 PMC: 6819924. DOI: 10.1128/JVI.00742-19.